• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。

Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.

作者信息

Girolami A, Patrassi O, Cella G

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.

PMID:72033
Abstract

Thrombotest clotting times of mixtures of coumarin plasmas and normal plasma yielded a patterm similar to that observed in mixtures of plasma with congenital coagulation disorders and normal plasma. The presence of 10 or 20% of test plasma in the mixture failed to affect the clotting times which resulted in normal limits. The only exception to this rule was the hemophilia BM plasma. In this case even the presence of 10-20% of patient plasma in the mixture caused a prolongation of the clotting time. This indicates that no inhibitor is present in coumarin plasmas and in the plasma of congenital coagulation disorders of the prothrombin complex save for hemophilia BM plasma which does contain an inhibitor.

摘要

香豆素血浆与正常血浆混合物的凝血酶试验凝血时间产生的模式,类似于在患有先天性凝血障碍的血浆与正常血浆混合物中观察到的模式。混合物中10%或20%的测试血浆的存在并未影响凝血时间,其结果仍在正常范围内。该规则的唯一例外是血友病B型血浆。在这种情况下,即使混合物中存在10%-20%的患者血浆,也会导致凝血时间延长。这表明除了确实含有抑制剂的血友病B型血浆外,香豆素血浆和凝血酶原复合物先天性凝血障碍的血浆中不存在抑制剂。

相似文献

1
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.
2
Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.凝血酶原复合物先天性凝血障碍及香豆素治疗患者中正常凝血试验与血栓形成试验的差异:一种非特异性现象。
Am J Clin Pathol. 1977 Jan;67(1):57-60. doi: 10.1093/ajcp/67.1.57.
3
Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.玻璃激活诱导的凝血酶原复合物先天性凝血障碍中正常凝血酶原时间-凝血酶时间差异的降低或消失。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(2):283-93.
4
[Mixing test for prolonged clotting time: clinical availability and problems].[凝血时间延长的混合试验:临床实用性与问题]
Rinsho Byori. 2009 Oct;57(10):1004-12.
5
Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.通过放射免疫测定法检测因子IX抗原。华法林治疗患者及血友病B患者中的异常因子IX蛋白。
J Clin Invest. 1977 May;59(5):900-10. doi: 10.1172/JCI108712.
6
Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.因子IX同种抗体可缩短正常人血浆的牛凝血酶原时间。
Thromb Haemost. 1981 Dec 23;46(4):684-6.
7
Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.促凝磷脂在狼疮抗凝物检测中的干扰作用检测
Thromb Res. 2004;114(5-6):547-52. doi: 10.1016/j.thromres.2004.06.001.
8
Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.随着抗凝作用增强,稀释曲线系统中“抑制作用”明显降低。这是一个与香豆素治疗患者中存在抑制剂相悖的悖论。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(5):670-6.
9
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).非抗凝硫酸多糖(NASP)改善出血性疾病中的凝血功能。
Thromb Haemost. 2006 Jan;95(1):68-76.
10
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.

引用本文的文献

1
A new family with classical factor X deficiency as demonstrated by electroimmunoassay.通过免疫电泳法证实的一个患有典型因子X缺乏症的新家族。
Blut. 1983 Jul;47(1):53-7. doi: 10.1007/BF00321050.
2
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.